[Translation] A phase III multicenter, randomized, single-blind (evaluator-blind), parallel, parallel, phase III study evaluating the efficacy and safety of OPC-1085EL eye drops in Chinese subjects with primary open-angle glaucoma or ocular hypertension. Positive Controlled Clinical Trials
主要目的
以原发性开角型青光眼或高眼压症中国受试者为对象,评价OPC-1085EL 滴眼液与0.005%拉坦前列素滴眼液相比的降眼压作用的优效性。
次要目的
比较OPC-1085EL滴眼液与0.005%拉坦前列素滴眼液使用的安全性。
[Translation] main purpose
To evaluate the superiority of OPC-1085EL eye drops compared with 0.005% latanoprost eye drops in lowering intraocular pressure in Chinese subjects with primary open-angle glaucoma or ocular hypertension.
secondary purpose
To compare the safety of the use of OPC-1085EL eye drops with 0.005% latanoprost eye drops.